Back to Search Start Over

Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018.

Authors :
Ritchie LA
Harrison SL
Penson PE
Akbari A
Torabi F
Hollinghurst J
Harris D
Oke OB
Akpan A
Halcox JP
Rodgers SE
Lip GYH
Lane DA
Source :
Age and ageing [Age Ageing] 2022 Dec 05; Vol. 51 (12).
Publication Year :
2022

Abstract

Objective: To determine atrial fibrillation (AF) prevalence and temporal trends, and examine associations between AF and risk of adverse health outcomes in older care home residents.<br />Methods: Retrospective cohort study using anonymised linked data from the Secure Anonymised Information Linkage Databank on CARE home residents in Wales with AF (SAIL CARE-AF) between 2003 and 2018. Fine-Gray competing risk models were used to estimate the risk of health outcomes with mortality as a competing risk. Cox regression analyses were used to estimate the risk of mortality.<br />Results: There were 86,602 older care home residents (median age 86.0 years [interquartile range 80.8-90.6]) who entered a care home between 2003 and 2018. When the pre-care home entry data extraction was standardised, the overall prevalence of AF was 17.4% (95% confidence interval 17.1-17.8) between 2010 and 2018. There was no significant change in the age- and sex-standardised prevalence of AF from 16.8% (15.9-17.9) in 2010 to 17.0% (16.1-18.0) in 2018. Residents with AF had a significantly higher risk of cardiovascular mortality (adjusted hazard ratio [HR] 1.27 [1.17-1.37], P < 0.001), all-cause mortality (adjusted HR 1.14 [1.11-1.17], P < 0.001), ischaemic stroke (adjusted sub-distribution HR 1.55 [1.36-1.76], P < 0.001) and cardiovascular hospitalisation (adjusted sub-distribution HR 1.28 [1.22-1.34], P < 0.001).<br />Conclusions: Older care home residents with AF have an increased risk of adverse health outcomes, even when higher mortality rates and other confounders are accounted for. This re-iterates the need for appropriate oral anticoagulant prescription and optimal management of cardiovascular co-morbidities, irrespective of frailty status and predicted life expectancy.<br /> (© The Author(s) 2022. Published by Oxford University Press on behalf of the British Geriatrics Society.)

Details

Language :
English
ISSN :
1468-2834
Volume :
51
Issue :
12
Database :
MEDLINE
Journal :
Age and ageing
Publication Type :
Academic Journal
Accession number :
36469091
Full Text :
https://doi.org/10.1093/ageing/afac252